EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients ...

When we published our 2024 report, children suffering from Leber Congenital Amaurosis 4 (LCA4)—a severe inherited retinal ...

EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced ...

If you haven’t had the opportunity to try Dr. Whitney Bowe Beauty, I recommend you remedy that now during a rare, 25 percent ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

New research reveals a retinal light test may hold the key to detecting Parkinson's disease long before motor symptoms appear ...

Thousands of people with eye injuries in the Gaza Strip face the risk of losing their vision due to the urgent need for ...

Researchers found the therapy downregulated VEGF expression and improved retinal thickness in neovascular age-related macular degeneration patients.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Patients with intermittent exotropia experience retinal thinning in the temporal parafoveal region, a study shows.

SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt ...

It’s a good thing you came in now,” a nurse told me before preparing my right eye for numbing drops, an injection and the ...